Key result
Right ventricular tissue contains a significantly higher percentage of cardiac mesenchymal stromal cells compared to left ventricular tissue (19.75% vs 11.05%, p=0.001), alongside distinct functional and transcriptomic differences.
Why the study?
Scarce information is available regarding chamber-specific cellular peculiarities between the LV and RV, and differential features distinguishing LV from RV C-MSC remain underappreciated.
Do human cardiac mesenchymal stromal cells differ in number, function, and transcriptomic profile between the right and left ventricles?
Observational (n=13)
Do human cardiac mesenchymal stromal cells differ in number, function, and transcriptomic profile between the right and left ventricles?
Human cardiac mesenchymal stromal cells exhibit distinct chamber-specific differences in number, function, and transcriptomic profiles between the right and left ventricles.
RV stromal cell enrichment may guide chamber-specific regenerative strategies; hypothesis-generating and requires functional validation before clinical consideration.
BACKGROUND: Left ventricle (LV) and right ventricle (RV) are characterized by well-known physiological differences, mainly related to their different embryological origin, hemodynamic environment, function, structure, and cellular composition. Nevertheless, scarce information is available about cellular peculiarities between left and right ventricular chambers in physiological and pathological contexts. Cardiac mesenchymal stromal cells (C-MSC) are key cells affecting many functions of the heart. Differential features that distinguish LV from RV C-MSC are still underappreciated. AIM: To analyze the physiological differential amount, function, and transcriptome of human C-MSC in LV versus (vs.) RV. METHODS: Human cardiac specimens of LV and RV from healthy donors were used for tissue analysis of C-MSC number, and for C-MSC isolation. Paired LV and RV C-MSC were compared as for surface marker expression, cell proliferation/death ratio, migration, differentiation capabilities, and transcriptome profile. RESULTS: Histological analysis showed a greater percentage of C-MSC in RV vs. LV tissue. Moreover, a higher C-MSC amount was obtained from RV than from LV after isolation procedures. LV and RV C-MSC are characterized by a similar proportion of surface markers. Functional studies revealed comparable cell growth curves in cells from both ventricles. Conversely, LV C-MSC displayed a higher apoptosis rate and RV C-MSC were characterized by a higher migration speed and collagen deposition. Consistently, transcriptome analysis showed that genes related to apoptosis regulation or extracellular matrix organization and integrins were over-expressed in LV and RV, respectively. Besides, we revealed additional pathways specifically associated with LV or RV C-MSC, including energy metabolism, inflammatory response, cardiac conduction, and pluripotency. CONCLUSION: Taken together, these results contribute to the functional characterization of RV and LV C-MSC in physiological conditions. This information suggests a possible differential role of the stromal compartment in chamber-specific pathologic scenarios.
No takes yet. Share an insight, caveat, or question.
Stadiotti et al. (2020) conducted an observational in Healthy donors (n=13). Right ventricle origin vs. Left ventricle origin was evaluated on Percentage of CD44+ cardiac mesenchymal stromal cells in tissue (p=0.001). Right ventricular tissue contains a significantly higher percentage of cardiac mesenchymal stromal cells compared to left ventricular tissue (19.75% vs 11.05%, p=0.001), alongside distinct functional and transcriptomic differences.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: